Lycopene Embedded into Cocoa Butter Micelles of Dark Chocolate Causes Dose-dependent Decrease in Serum Lipids of Hypercholesterolemic Volunteers
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 13, Issue 11
Abstract
Aim: To investigate if different amounts of lycopene embedded into cocoa butter micelles of dark chocolate affect serum lipid profile of hypercholesterolemia patients. Study Design: 32 clinically healthy volunteers with borderline hyperlipidemia were enrolled in a 4 week dietary trial. The study participants ingested daily one 10 g bar of L-tug dark chocolate (DC) which contained 0, 2, 3.5 or 7 mg of lycopene with no other restrictions/modifications to their habitual diet. Serum specimens were collected at the outset and after the second and fourth weeks of the trial. The study was conducted at the Saratov’s Institute of Cardiology (Russian Federation) using dark chocolate specimens provided by Lycotec Ltd (Cambridge, UK) during January-March 2013 under approved and registered protocol. Results: It was found that even the lowest concentration of lycopene tested (2 mg) caused a statistically significant (p<0.05) decline in the total cholesterol value at the end of the trial [from a median of 230.5 mg/dl (95% CI: 243.6, 204.8) to 210.5 mg/dl (95%CI: 221.7, 200.1)]. Consumption of higher amounts of lycopene embedded into L-tug DC caused an even more significant step-wise decline in total cholesterol values which were observable from the second week of the trial. There was a corresponding decline in LDL-cholesterol and triglyceride values. Consumption of L-tug DC with the highest amount of lycopene (7 mg) caused a small but statistically significant (P<0.05) increase in HDL values at the end of the interventional period [from a median of 40 mg/dl (95% CI: 43.65, 39) to 42 (95%CI: 43.65, 40.35)]. Conclusion: Lycopene-containing L-tug DC can be used for dietary management of abnormalities of lipid homeostasis in mild hyperlipidemia.
Authors and Affiliations
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle
Keywords
Related Articles
- EP ID EP340753
- DOI 10.9734/BJMMR/2016/23623
- Views 49
- Downloads 0
Hepatitis B Virus Total Core Antibodies among HIV-1 Infected Hepatitis B Surface Antigen Negative Patients Attending a Tertiary Health Facility in North-central Nigeria
Aims: The aim of this study was to determine the prevalence of total Hepatitis B core antibodies (anti-HBc) among HIV-1 infected adults without Hepatitis-B surface antigen (HBsAg). Study Design: Observational cross-secti...
Urinary Tract Infection in Children
We selected the pediatric urinary tract infection related research and review articles in English language using keywords or phrases such as Infant; children; culture; Escherichia coli; fever, UTI. Aims: The purpose of t...
Social Skills Training Encourages a Patient with Social Anxiety Disorder to Undertake Challenging Behavioral Experiments
Introductions: Cognitive models of social anxiety disorder (SAD), such as that developed by Clark & Wells, conceptualize the attention to, and misinterpretation of, internal information as a key maintaining factor. Socia...
Basic Fibroblast Growth Factor (bFGF), Fibroblast Growth Factor Receptor 1 (FGFR1), Transforming Growth Factor Beta (TGF-β) and Chromogranin A (CgA) Appearance in Congenital Intra-abdominal Adhesions in Children under One Year of Age
Aim: Of this work was to determine dispersion of TGF-b, fibrosis modulating factor (bFGF and FGR1) and granule marker chromogranin A in case of intra-abdominal adhesion which could be essential factors in disease pathoge...
Serum Chemerin and Cardiovascular Risk Factors in Diabetic Subjects without Established Vascular Disease
Aims: The current study aims to investigate serum chemerin as a potential cardiovascular marker in diabetic patients without established vascular diseases. Study Design: Case-Control study. Place and Duration of Study:...